Skip to content

A prospective study on the application of whole exon sequencing in multidisciplinary screening and diagnosis as swell as treatment of hereditary kidney diseases

A prospective study on the application of whole exon sequencing in multidisciplinary screening and diagnosis as swell as treatment of hereditary kidney diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055856
Enrollment
Unknown
Registered
2022-01-20
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hereditary kidney disease

Interventions

Case series:None

Sponsors

Provincial Hospital affiliated to Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The inclusion criteria for children (< 18 years old) who met any of the following specific clinical symptoms: (1)Intermittent severe extremity pain or paresthesia; (2)Angiokeratomas; (3)Hypohidrosis or anhidrosis or heat or cold intolerance or recurrent fever; (4)Cornea verticillata ; (5)Unexplained proteinuria, hematuria, chronic kidney disease, renal failure, renal replacement therapy (dialysis, kidney transplantation); (6)Family history of the above symptoms; 2. The inclusion criteria for adults who met any of the following specific clinical symptoms: (1)Department of Nephrology : unexplained proteinuria, hematuria, chronic kidney disease; (2)Department of Cardiology: unexplained hypertrophic cardiomyopathy, arrhythmia, heart failure; (3)Department of Neurology: middle-young stroke patients with unknown cause; (4)Family history of chronic kidney disease or hypertrophic cardiomyopathy; 3. Accompanied or previously accompanied with any of the following specific clinical symptoms: (1)Intermittent severe extremity pain or paresthesia; (2)Angiokeratomas; (3)Hypohidrosis or anhidrosis or heat or cold intolerance or recurrent fever; (4)Cornea verticillata,hearing loss; (5)Family history of the above symptoms.

Exclusion criteria

Exclusion criteria: 1.Hypertensive or diabetic nephropathy confirmed by renal biopsy; 2.Secondary causes such as SLE, AAV, henoch-schonlein purpura, hereditary kidney disease confirmed by previous genetic testing, or other confirmed kidney diseases, or underwent bilateral native kidneys nephrectomy; 3.Confirmed diseases that lead to cardiac hypertrophy, arrhythmia, or heart failure (e.g., hypertrophic cardiomyopathy, glycogen storage disease, primary carnitine deficiency, myocardial amyloidosis, aortic disease, etc.); 4.Confirmed diseases that lead to stroke in young-middle people (such as lupus arteritis, polyarteritis nodosa multiple arteritis, temporal arteritis, non-specific obliterans arteritis, fibromuscular dysplasia, hemangioma and cerebrovascular malformation, blood system diseases, etc.); 5.Confirmed diseases that lead to extremity pain (such as rheumatoid arthritis, osteoarthritis, diabetic peripheral neuropathy, etc.); 6.Confirmed diseases that lead to skin spot (henoch-schonlein purpura, a skin rash or other types of angioblastoma, etc.).

Design outcomes

Primary

MeasureTime frame
Whole exome sequencing;

Countries

China

Contacts

Public ContactWang Rong

Provincial Hospital affiliated to Shandong First Medical University

wangrong@sdfmu.edu.cn+86 531 68778329

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026